Skip to main content
logo
Granules India Limited (NSE:GRANULES)
India flag India · Delayed Price · Currency is INR
563.70
-16.00 (-2.76%)
At close: Feb 6, 2026

Granules India Revenue

Granules India had revenue of 13.88B INR in the quarter ending December 31, 2025, with 22.00% growth. This brings the company's revenue in the last twelve months to 50.92B, up 14.18% year-over-year. In the fiscal year ending March 31, 2025, Granules India had annual revenue of 44.82B, down -0.55%.

Revenue (ttm)
50.92B
Revenue Growth
+14.18%
P/S Ratio
2.69
Revenue / Employee
12.52M
Employees
4,066
Market Cap
136.94B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202544.82B-247.59M-0.55%
Mar 31, 202445.06B-55.50M-0.12%
Mar 31, 202345.12B7.47B19.84%
Mar 31, 202237.65B5.27B16.29%
Mar 31, 202132.38B6.39B24.59%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Piramal Pharma88.71B
Emcure Pharmaceuticals87.96B
Alembic Pharmaceuticals70.83B
Strides Pharma Science47.26B
NATCO Pharma43.90B
Akums Drugs and Pharmaceuticals41.10B
Wockhardt30.07B
Eris Lifesciences29.86B
Revenue Rankings

Granules India News

More News